
Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma
Researchers from the University of Tsukuba, Japan, show that angioimmunoblastic T-cell lymphoma (AITL) is dependent…
Researchers from the University of Tsukuba, Japan, show that angioimmunoblastic T-cell lymphoma (AITL) is dependent…
A new study has identified a drug that potentially could make a common type of…
A drug already approved for leukaemia patients could also be used to treat a specific type…
Lung cancer is one of the most prevalent types of cancer, with more than 20,000…